Federman & Sherwood Investigates McPherson Hospital for Data Breach |...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 3, 2023

Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting • LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemo • Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery • Bijou Ikli named new CEO by Florida Assisted Living Association • Statement from Minister Hutchings on progress in support of rural Canadians • Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf • Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i • Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Cl • 56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award • Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i • The Assembly of First Nations and the Government of Canada announce updates to school design standards for schools on-reserve • KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line • Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research • UNice Celebrates LGBTQ Pride Month • Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam • San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat • Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting • Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin • Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y • High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy

Federman & Sherwood Investigates McPherson Hospital for Data Breach

OKLAHOMA CITY , May 26 /Businesswire/ - The law firm of Federman & Sherwood has initiated an investigation into McPherson Hospital, located in McPherson, Kansas, with respect to their July 2022 data breach. On May 5, 2023, McPherson Hospital notified patients that the company experienced a data breach after an unauthorized party accessed sensitive consumer data entrusted to the company. According to McPherson Hospital, they determined that information stored on their servers may have been subject to unauthorized access prior to July 12, 2022. McPherson Hospital determined that the information exposed in the data breach includes: names, addresses, Social Security numbers, driver’s license numbers, financial information, medical information (including diagnoses, medications and test results) and health insurance information.

If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Lacrista A. Bagley either by email at lab@federmanlaw.com or visit our firm’s website www.federmanlaw.com.